Subspecialties: Page 308

Kalender: Tell your patients about CT's benefits, not risks
By Philip Ward
CT is thriving, and instead of informing patients about the risk of radiation-induced cancer, now's the time to emphasize the upside of undergoing an examination, according to CT pioneer Willi Kalender, PhD. Tell them CT saves lives, he said in a special lecture.
August 4, 2015
2013 03 09 12 06 07 287 2013 03 09 Kalendar Willi 175 20150804175630
Brainreader launches MRI software
By AuntMinnieEurope.com staff writers
Danish medical device company Brainreader has launched its new Neuroreader software, which is designed to detect changes in a patient's brain volume.
August 3, 2015
IBA divests North American subsidiary
By AuntMinnieEurope.com staff writers
Proton therapy developer Ion Beam Applications (IBA) has completed the divestiture of IBA Molecular North America to Illinois Health and Science.
August 2, 2015
DBT boosts mammo's specificity, lowers recall rate
By Kate Madden Yee
Adding digital breast tomosynthesis (DBT) to conventional mammography boosted the specificity of breast screening and cut the recall of women with benign lesions by more than half in a new study published in Radiology. DBT plus mammography also showed sensitivity gains in some groups of women.
July 30, 2015
2014 04 10 15 30 43 349 Dbt Digital Breast Tomosynthesis 200
U.K. hospitals fall short in pediatric x-ray, audit finds
By AuntMinnieEurope.com staff writers
An audit by the Royal College of Radiologists has revealed U.K. hospitals are failing in their pediatric x-ray services.
July 27, 2015
Think twice on abdominal x-rays in emergencies
By Philip Ward
The excessive use of abdominal radiography in the emergency department adds financial strain, increases patient discomfort, and may even be a source of future litigation, U.K. researchers have found.
July 27, 2015
2015 07 27 11 44 55 160 X Ray Abdomen
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The 243.5 million euro deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The $270 million deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Perma-Fix subsidiary partners with Digirad for Tc-99m deal
By AuntMinnieEurope.com staff writers
Perma-Fix Environmental Services announced that its Polish subsidiary, Perma-Fix Medical, has finalized its partnership with nuclear medicine firm Digirad regarding technetium-99m (Tc-99m).
July 26, 2015
Mammography screening at 40 works, Lancet study finds
By Rebekah Moan
There is indeed a reduction in breast cancer mortality as a result of mammography screening in women who start getting exams at age 40 -- at least in the first 10 years of follow-up, according to a new study in Lancet Oncology that followed women for 17 years.
July 26, 2015
2014 04 16 12 05 28 295 Mammogram Patient 200
Functional MRI sheds light on placebo effect
A new study using functional MRI has shown what happens in the brain when a placebo is given, and it also highlights aspects that can help the doctor-patient relationship, according to Dr. Nina Theysohn, a radiologist from Essen, Germany.
July 23, 2015
2015 07 23 11 13 41 704 2015 07 24 Drg Placebo Thumb
Blue Earth secures $28M in venture capital
By AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.
July 22, 2015
Previous Page
Page 308 of 566
Next Page